Evidence map›Paper›PMID 39124560›Full record

ReviewJournal of clinical medicine2024

Exploring Type IIIb Endoleaks: A Literature Review to Identify Possible Physical Mechanisms and Implications.

Tuna Aras, Mahmoud Tayeh, Adel Aswad, Mohamed Sharkawy, Payman Majd

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. AFX catheter retention with type III endoleak.Journal of vascular surgery cases and innovative techniques · 2026
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tuna ArasVascular Surgery Department, EVK Bergish Gladbach Ferrenbergstraße, 51465 Bergisch Gladbach, Germany.
Mahmoud TayehVascular Surgery Department, EVK Bergish Gladbach Ferrenbergstraße, 51465 Bergisch Gladbach, Germany.
Adel AswadAl-Qassimi Teaching Hospital and Cardiac Centre, University of Sharjah, Sharjah P.O. Box 3500, United Arab Emirates.
Mohamed SharkawyCairo University Hospitals, Cairo Governorate 4240310, Egypt.ORCID 0000-0001-6263-2554
Payman MajdVascular Surgery Department, EVK Bergish Gladbach Ferrenbergstraße, 51465 Bergisch Gladbach, Germany.ORCID 0000-0002-5835-8318

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endoleaks are common complications following endovascular aneurysm repair (EVAR). They can be classified into low-pressure and high-pressure endoleaks. High-pressure endoleaks, which include Type I and Type III endoleaks, pose a significant risk of rupture and require urgent treatment. The aim of our study is to review published case reports and case series to assess the impact of Type IIIb endoleaks in EVAR and to identify possible mechanisms contributing to these endoleaks. This review targeted case reports and case series published between January 1998 and December 2022. A total of 62 case reports and case series were identified, encompassing 156 patients with Type IIIb endoleaks. Data collection was performed by three consultants who thoroughly discussed each report before registering it into an analyzable data set. Our analysis revealed that, beyond material imperfections, certain endograft configurations or conformations, endograft redundancy, and the physical forces acting on the grafts may lead to increased stress on specific parts of the endografts, potentially exceeding their design limits. Factors contributing to redundancy and unfavorable conformation of the endograft include secondary interventions for any cause (such as other types of endoleaks), EVAR performed outside the instructions for use (IFUs), endograft migrations, or larger initial aneurysm diameter.

Indexed as

abdominal aortic aneurysmendoleak type IIIBEVAR

Identifiers

PMID39124560
PMCPMC11312643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.